Haemonetics Goodwill and Intangible Assets 2010-2025 | HAE

Haemonetics goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Haemonetics Annual Goodwill and Intangible Assets
(Millions of US $)
2025 $1,060
2024 $971
2023 $742
2022 $778
2021 $832
2020 $344
2019 $339
2018 $368
2017 $388
2016 $472
2015 $579
2014 $608
2013 $595
2012 $212
2011 $217
2010 $210
2009 $122
Haemonetics Quarterly Goodwill and Intangible Assets
(Millions of US $)
2025-06-30 $1,058
2025-03-31 $1,060
2024-12-31 $1,071
2024-09-30 $1,104
2024-06-30 $1,108
2024-03-31 $971
2023-12-31 $984
2023-09-30 $716
2023-06-30 $734
2023-03-31 $742
2022-12-31 $750
2022-09-30 $758
2022-06-30 $769
2022-03-31 $778
2021-12-31 $792
2021-09-30 $806
2021-06-30 $820
2021-03-31 $832
2020-12-31 $335
2020-09-30 $342
2020-06-30 $355
2020-03-31 $344
2019-12-31 $318
2019-09-30 $325
2019-06-30 $331
2019-03-31 $339
2018-12-31 $345
2018-09-30 $352
2018-06-30 $360
2018-03-31 $368
2017-12-31 $375
2017-09-30 $381
2017-06-30 $384
2017-03-31 $388
2016-12-31 $453
2016-09-30 $461
2016-06-30 $467
2016-03-31 $472
2015-12-31 $482
2015-09-30 $571
2015-06-30 $576
2015-03-31 $579
2014-12-31 $586
2014-09-30 $594
2014-06-30 $602
2014-03-31 $608
2013-12-31 $612
2013-09-30 $619
2013-06-30 $621
2013-03-31 $595
2012-12-31 $595
2012-09-30 $620
2012-06-30 $210
2012-03-31 $212
2011-12-31 $212
2011-09-30 $214
2011-06-30 $217
2011-03-31 $217
2010-12-31 $211
2010-09-30 $207
2010-06-30 $202
2010-03-31 $210
2009-12-31 $146
2009-09-30 $147
2009-06-30 $137
2009-03-31 $122
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.716B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.767B 27.06
Boston Scientific (BSX) United States $157.318B 37.52
Stryker (SYK) United States $150.713B 30.68
EssilorLuxottica (ESLOY) France $147.808B 0.00
Medtronic (MDT) Ireland $118.836B 16.76
Lonza Group Ag (LZAGY) Switzerland $49.610B 0.00
Haleon (HLN) United Kingdom $44.076B 25.18
ResMed (RMD) United States $43.006B 30.76
Agilent Technologies (A) United States $34.551B 22.52
GE HealthCare Technologies (GEHC) United States $34.343B 16.14
Terumo (TRUMY) Japan $27.701B 32.82
Koninklijke Philips (PHG) Netherlands $27.289B 18.05
Insulet (PODD) United States $23.284B 78.01
Zimmer Biomet Holdings (ZBH) United States $21.337B 13.58
Smith & Nephew SNATS (SNN) United Kingdom $16.420B 0.00
Baxter (BAX) United States $12.604B 9.74
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Bio-Rad Laboratories (BIO) United States $8.222B 30.20
Demant (WILYY) Denmark $8.121B 0.00
Lantheus Holdings (LNTH) United States $3.958B 10.70
Envista Holdings (NVST) United States $3.609B 25.26
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.369B 8.42
Prestige Consumer Healthcare (PBH) United States $3.283B 14.57
ICU Medical (ICUI) United States $3.164B 21.54
LeMaitre Vascular (LMAT) United States $2.271B 48.70
Acuren (TIC) United States $2.108B 0.00
QuidelOrtho (QDEL) United States $1.894B 11.92
Curaleaf Holdings (CURLF) Canada $1.891B 0.00
AtriCure (ATRC) United States $1.872B 0.00
Green Thumb Industries (GTBIF) United States $1.757B 75.45
Phibro Animal Health (PAHC) United States $1.316B 16.82
AdaptHealth (AHCO) United States $1.300B 18.48
Tilray Brands (TLRY) Canada $1.266B 0.00
BioLife Solutions (BLFS) United States $1.241B 2591.00
Neogen (NEOG) United States $1.225B 19.45
Valneva SE (VALN) France $0.990B 0.00
Kestra Medical Technologies (KMTS) United States $0.954B 0.00
InMode (INMD) Israel $0.936B 8.66
Maravai LifeSciences Holdings (MRVI) United States $0.624B 0.00
Cresco Labs (CRLBF) United States $0.607B 0.00
SNDL (SNDL) Canada $0.591B 0.00
Verano Holdings (VRNOF) United States $0.561B 0.00
ZimVie (ZIMV) United States $0.534B 20.60
Surmodics (SRDX) United States $0.532B 0.00
Evolus (EOLS) United States $0.497B 0.00
VAREX IMAGING (VREX) United States $0.482B 16.60
CeriBell (CBLL) United States $0.442B 0.00
Owens & Minor (OMI) United States $0.390B 3.46
Sanuwave Health (SNWV) United States $0.386B 0.00
Capricor Therapeutics (CAPR) United States $0.325B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
TerrAscend (TSNDF) Canada $0.306B 0.00
Canopy Growth (CGC) Canada $0.305B 0.00
Sanara MedTech (SMTI) United States $0.302B 0.00
Omeros (OMER) United States $0.299B 0.00
High Tide (HITI) Canada $0.290B 0.00
Brainsway (BWAY) Israel $0.287B 58.46
Viemed Healthcare (VMD) United States $0.284B 21.50
Aurora Cannabis (ACB) Canada $0.282B 0.00
Cerus (CERS) United States $0.243B 0.00
Vireo Growth (VREOF) United States $0.241B 0.00
Quanterix (QTRX) United States $0.224B 0.00
Exagen (XGN) United States $0.222B 0.00
OraSure Technologies (OSUR) United States $0.219B 0.00
Organigram Global (OGI) Canada $0.214B 0.00
Utah Medical Products (UTMD) United States $0.195B 16.30
TriSalus Life Sciences (TLSI) United States $0.191B 0.00
FitLife Brands (FTLF) United States $0.160B 19.65
Biote (BTMD) United States $0.159B 5.28
Jushi Holdings (JUSHF) United States $0.133B 0.00
Jin Medical (ZJYL) China $0.113B 0.00
MacroGenics (MGNX) United States $0.107B 0.00
Fonar (FONR) United States $0.095B 12.19
Quipt Home Medical (QIPT) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Safety Shot (SHOT) United States $0.070B 0.00
Agape ATP (ATPC) $0.066B 0.00
Cytosorbents (CTSO) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.055B 32.07
Veru (VERU) United States $0.053B 0.00
Zynex (ZYXI) United States $0.050B 0.00
Nephros (NEPH) United States $0.044B 34.83
Modular Medical (MODD) United States $0.040B 0.00
Rockwell Medical (RMTI) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 14.95
Trinity Biotech (TRIB) Ireland $0.028B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.018B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Sharps Technology (STSS) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00